TRCT
BCAB

Tower Research Capital (TRC)’s BIOATLA INC BCAB Stock Holding History

Tower Research Capital (TRC)’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57K Buy
863
+523
+154% +$2.22K ﹤0.01% 4509
2026
Q1 		$2.74K Buy
340
+234
+221% +$2.74K ﹤0.01% 4424
2025
Q4 		$3.02K Buy
+106
New +$4.16K ﹤0.01% 4434
2025
Q3 		– Sell
-466
Closed -$9.23K – 5225
2025
Q2 		$9.23K Buy
+466
New +$9.45K ﹤0.01% 3996
2025
Q1 		– Sell
-119
Closed -$3.51K – 5195
2024
Q4 		$3.51K Buy
119
+16
+16% +$1.34K ﹤0.01% 4646
2024
Q3 		$9.04K Sell
103
-254
-71% -$21.3K ﹤0.01% 3912
2024
Q2 		$24.5K Buy
357
+327
+1,090% +$38.9K ﹤0.01% 3641
2024
Q1 		$5.16K Sell
30
-68
-69% -$8.45K ﹤0.01% 4579
2023
Q4 		$12.1K Sell
98
-56
-36% -$4.86K ﹤0.01% 4075
2023
Q3 		$13.1K Buy
154
+61
+66% +$7.78K ﹤0.01% 3828
2023
Q2 		$13.9K Sell
93
-133
-59% -$22.9K ﹤0.01% 3731
2023
Q1 		$30K Buy
226
+94
+71% +$16.9K ﹤0.01% 2983
2022
Q4 		$54K Buy
132
+92
+230% +$38.2K ﹤0.01% 2286
2022
Q3 		$15K Sell
40
-62
-61% -$20.3K ﹤0.01% 4154
2022
Q2 		$14K Sell
102
-49
-32% -$7.8K ﹤0.01% 4127
2022
Q1 		$37K Buy
151
+65
+76% +$27.2K ﹤0.01% 2955
2021
Q4 		$84K Buy
86
+30
+54% +$38.4K ﹤0.01% 2346
2021
Q3 		$83K Buy
56
+46
+460% +$89.6K ﹤0.01% 2544
2021
Q2 		$20K Sell
10
-20
-67% -$45.2K ﹤0.01% 3871
2021
Q1 		$76K Buy
+30
New +$76.9K ﹤0.01% 2792

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tower Research Capital (TRC)'s BCAB Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its BIOATLA INC (BCAB) stake by 154% in Q2 2026, buying an estimated $2.22K and bringing the position to 863 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4509.

Tower Research Capital (TRC) first reported a position in BCAB in Q1 2021 and has held it in 20 quarters since. The position peaked at $84K in Q4 2021. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Tower Research Capital (TRC) held 863 shares of BIOATLA INC worth $3.57K as of Q2 2026.
  • Tower Research Capital (TRC) bought 523 BIOATLA INC shares in Q2 2026, an estimated $2.22K.
  • BIOATLA INC made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4509 holding.
  • Tower Research Capital (TRC) first reported a position in BIOATLA INC in Q1 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s BIOATLA INC position peaked at $84K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.